{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:02:39Z","timestamp":1790182959574,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Society of interventional Oncology SIO","award":["2022 Combined Locoregional and Immunotherapy of HCC Research grant"],"award-info":[{"award-number":["2022 Combined Locoregional and Immunotherapy of HCC Research grant"]}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["#2406\/24"],"award-info":[{"award-number":["#2406\/24"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol Exp"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We investigated the extent of cellular, transcriptional, and translational activation throughout the liver following radiofrequency ablation (RFA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>RFA of the healthy liver was performed in two 8\u201310-week-old male C57\/Bl6 mice, no\/sham procedure in one. One and 7 days after, single-cell RNA sequencing (scRNAseq) was performed on distant, untreated liver to examine &gt;\u20096,000 genes from normalized datasets of &gt;\u20096,000 cells\/sample, enabling identification of ten major cell populations. We defined cell-to-cell interactions by CellphoneDB and identified active pathways via STRING-db analysis with Markov clustering. Twelve distant liver lobe samples were homogenized on day 3 or day 6 after RFA\/sham procedure for SomaLogic proteomic analysis (&gt;\u20091,300 genes), subsequent STRING-db analysis, and assessment of cellular origin (PanglaoDB-2021).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CellphoneDB identified crosstalk among all ten populations with 4,658 and 4,218 receptor\/ligand pairs, identified on day 1 and day 7 post-RFA, respectively. On day 1, 360 differentially expressed genes were identified; on day 7, 430. Activated genes distributed into 16 clusters, including 66 chemokines\/cytokines, including Ccl2 and Ccl7; 57 immunomodulators, including Il6, Ctla4 and Pdcd1; and 54 growth factors, including Vegf, Hgf, Pdgf, and Fgf. Angiogenesis pathway genes were observed in endothelial cells and hepatocytes. Pdcd1 and Ctla4 were notably increased transiently in T cells. Proteomic analysis included 228\/443 genes (51%) identified by scRNAseq; 73\/228 proteins (32%) demonstrated 25% elevation over controls. Overall, 427 proteins were elevated, with 9\/10 cell populations contributing to increased protein expression (odds ratio 4.9\u20127.0).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>RFA diffusely activates cellular processes remotely from the ablation zone on both transcriptional and translational levels, altering tumorigenic and immunologic pathways simultaneously.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Relevance statement<\/jats:title>\n                    <jats:p>This study offers insights into liver tissue biology after RFA and provides a comprehensive picture of the molecular mechanisms put into motion by this procedure. A better understanding of these processes could provide a potential basis to develop specific biomarkers and effective adjuvant therapies following local tumor ablation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>RFA activates a multiplicity of hepatic cellular processes remotely from the ablation zone on a transcriptional and translational level.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Single-cell RNA sequencing provides insights into widespread cellular origins of activated pro-immunogenic, pro-tumorigenic, and other pathways detected post-ablation.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Consideration of the nature of this response may help achieve the clinical goals of adjuvant therapies and predictive biomarkers.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s41747-026-00687-1","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:55:04Z","timestamp":1775123704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hepatic radiofrequency ablation induces widespread cellular activation throughout the liver"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1810-3529","authenticated-orcid":false,"given":"Matthias","family":"Stechele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Amadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Salvermoser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Sperlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Monin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Khademi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz Nikolaus","family":"Gr\u00f6per","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneeb","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eithan","family":"Galun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Ricke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shraga Nahum","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"687_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.annonc.2025.02.006","volume":"36","author":"A Vogel","year":"2025","unstructured":"Vogel A, Chan SL, Dawson LA et al (2025) Hepatocellular carcinoma: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol 36:491\u2013506. https:\/\/doi.org\/10.1016\/j.annonc.2025.02.006","journal-title":"Ann Oncol"},{"key":"687_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","volume":"82","author":"European Association for the Study of the Liver","year":"2025","unstructured":"European Association for the Study of the Liver (2025) EASL clinical practice guidelines on the management of hepatocellular carcinoma. J Hepatol 82:315\u2013374. https:\/\/doi.org\/10.1016\/j.jhep.2024.08.028","journal-title":"J Hepatol"},{"key":"687_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S1470-2045(24)00660-0","volume":"26","author":"S van der Lei","year":"2025","unstructured":"van der Lei S, Puijk RS, Dijkstra M et al (2025) Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial. Lancet Oncol 26:187\u2013199. https:\/\/doi.org\/10.1016\/S1470-2045(24)00660-0","journal-title":"Lancet Oncol"},{"key":"687_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejro.2023.100501","volume":"11","author":"P Hendriks","year":"2023","unstructured":"Hendriks P, Boel F, Oosterveer TT et al (2023) Ablation margin quantification after thermal ablation of malignant liver tumors: how to optimize the procedure? A systematic review of the available evidence. Eur J Radiol Open 11:100501. https:\/\/doi.org\/10.1016\/j.ejro.2023.100501","journal-title":"Eur J Radiol Open"},{"key":"687_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s00270-012-0377-1","volume":"36","author":"X Wang","year":"2013","unstructured":"Wang X, Sofocleous CT, Erinjeri JP et al (2013) Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc Interv Radiol 36:166\u2013175. https:\/\/doi.org\/10.1007\/s00270-012-0377-1","journal-title":"Cardiovasc Interv Radiol"},{"key":"687_CR6","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1148\/radiol.15141918","volume":"276","author":"N Rozenblum","year":"2015","unstructured":"Rozenblum N, Zeira E, Bulvik B et al (2015) Radiofrequency ablation: inflammatory changes in the periablative zone can induce global organ effects, including liver regeneration. Radiology 276:416\u2013425. https:\/\/doi.org\/10.1148\/radiol.15141918","journal-title":"Radiology"},{"key":"687_CR7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/RLI.0000000000000777","volume":"56","author":"F Collettini","year":"2021","unstructured":"Collettini F, Brangsch J, Reimann C et al (2021) Hepatic radiofrequency ablation: monitoring of ablation-induced macrophage recruitment in the periablational rim using SPION-enhanced macrophage-specific magnetic resonance imaging. Invest Radiol 56:591\u2013598. https:\/\/doi.org\/10.1097\/RLI.0000000000000777","journal-title":"Invest Radiol"},{"key":"687_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/02656736.2020.1714084","volume":"37","author":"A Markezana","year":"2020","unstructured":"Markezana A, Ahmed M, Kumar G et al (2020) Moderate hyperthermic heating encountered during thermal ablation increases tumor cell activity. Int J Hyperthermia 37:119\u2013129. https:\/\/doi.org\/10.1080\/02656736.2020.1714084","journal-title":"Int J Hyperthermia"},{"key":"687_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1148\/radiol.2015150080","volume":"279","author":"M Ahmed","year":"2016","unstructured":"Ahmed M, Kumar G, Moussa M et al (2016) Hepatic radiofrequency ablation-induced stimulation of distant tumor growth is suppressed by c-Met inhibition. Radiology 279:103\u2013117. https:\/\/doi.org\/10.1148\/radiol.2015150080","journal-title":"Radiology"},{"key":"687_CR10","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1148\/radiol.2017162943","volume":"286","author":"G Kumar","year":"2018","unstructured":"Kumar G, Goldberg SN, Gourevitch S et al (2018) Targeting STAT3 to suppress systemic pro-oncogenic effects from hepatic radiofrequency ablation. Radiology 286:524\u2013536. https:\/\/doi.org\/10.1148\/radiol.2017162943","journal-title":"Radiology"},{"key":"687_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1148\/radiol.2019191023","volume":"294","author":"H Liao","year":"2020","unstructured":"Liao H, Ahmed M, Markezana A et al (2020) Thermal ablation induces transitory metastatic growth by means of the STAT3\/c-Met molecular pathway in an intrahepatic colorectal cancer mouse model. Radiology 294:464\u2013472. https:\/\/doi.org\/10.1148\/radiol.2019191023","journal-title":"Radiology"},{"key":"687_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41368-021-00146-0","volume":"13","author":"X Li","year":"2021","unstructured":"Li X, Wang CY (2021) From bulk, single-cell to spatial RNA sequencing. Int J Oral Sci 13:36. https:\/\/doi.org\/10.1038\/s41368-021-00146-0","journal-title":"Int J Oral Sci"},{"key":"687_CR13","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s42003-020-01522-y","volume":"3","author":"NM Munoz","year":"2020","unstructured":"Munoz NM, Dupuis C, Williams M et al (2020) Molecularly targeted photothermal ablation improves tumor specificity and immune modulation in a rat model of hepatocellular carcinoma. Commun Biol 3:783. https:\/\/doi.org\/10.1038\/s42003-020-01522-y","journal-title":"Commun Biol"},{"key":"687_CR14","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M et al (2023) The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51:D638\u2013D646. https:\/\/doi.org\/10.1093\/nar\/gkac1000","journal-title":"Nucleic Acids Res"},{"key":"687_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY, Tan CM, Kou Y et al (2013) Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14:128. https:\/\/doi.org\/10.1186\/1471-2105-14-128","journal-title":"BMC Bioinformatics"},{"key":"687_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42819-2","volume":"13","author":"A Markezana","year":"2023","unstructured":"Markezana A, Paldor M, Liao H et al (2023) Fibroblast growth factors induce hepatic tumorigenesis post radiofrequency ablation. Sci Rep 13:16341. https:\/\/doi.org\/10.1038\/s41598-023-42819-2","journal-title":"Sci Rep"},{"key":"687_CR17","doi-asserted-by":"publisher","unstructured":"Franz\u00e9n O, Gan LM, Bj\u00f6rkegren JLM (2019) PanglaoDB: a web server for exploration of mouse and human single-cell RNA sequencing data. Database. https:\/\/doi.org\/10.1093\/database\/baz046","DOI":"10.1093\/database\/baz046"},{"key":"687_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/02656736.2021.1887942","volume":"38","author":"A Markezana","year":"2021","unstructured":"Markezana A, Goldberg SN, Kumar G et al (2021) Incomplete thermal ablation of tumors promotes increased tumorigenesis. Int J Hyperthermia 38:263\u2013272. https:\/\/doi.org\/10.1080\/02656736.2021.1887942","journal-title":"Int J Hyperthermia"},{"key":"687_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.101919","volume":"43","author":"L Salvermoser","year":"2024","unstructured":"Salvermoser L, Goldberg SN, Alunni-Fabbroni M et al (2024) CT-guided high dose rate brachytherapy can induce multiple systemic proteins of proliferation and angiogenesis predicting outcome in HCC. Transl Oncol 43:101919. https:\/\/doi.org\/10.1016\/j.tranon.2024.101919","journal-title":"Transl Oncol"},{"key":"687_CR20","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.jvir.2022.11.024","volume":"34","author":"M Stechele","year":"2023","unstructured":"Stechele M, Wildgruber M, Markezana A et al (2023) Prediction of protumorigenic effects after image-guided radiofrequency ablation of hepatocellular carcinoma using biomarkers. J Vasc Interv Radiol 34:1528\u20131537.e1. https:\/\/doi.org\/10.1016\/j.jvir.2022.11.024","journal-title":"J Vasc Interv Radiol"},{"key":"687_CR21","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrg3185","volume":"13","author":"C Vogel","year":"2012","unstructured":"Vogel C, Marcotte EM (2012) Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet 13:227\u2013232. https:\/\/doi.org\/10.1038\/nrg3185","journal-title":"Nat Rev Genet"},{"key":"687_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2022.100288","volume":"2","author":"SR Upadhya","year":"2022","unstructured":"Upadhya SR, Ryan CJ (2022) Experimental reproducibility limits the correlation between mRNA and protein abundances in tumor proteomic profiles. Cell Rep Methods 2:100288. https:\/\/doi.org\/10.1016\/j.crmeth.2022.100288","journal-title":"Cell Rep Methods"},{"key":"687_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.959987","volume":"12","author":"MA Kimm","year":"2022","unstructured":"Kimm MA, Kastle S, Stechele MMR et al (2022) Early monocyte response following local ablation in hepatocellular carcinoma. Front Oncol 12:959987. https:\/\/doi.org\/10.3389\/fonc.2022.959987","journal-title":"Front Oncol"},{"key":"687_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02787-1","volume":"11","author":"Q Fei","year":"2020","unstructured":"Fei Q, Pan Y, Lin W et al (2020) High-dimensional single-cell analysis delineates radiofrequency ablation induced immune microenvironmental remodeling in pancreatic cancer. Cell Death Dis 11:589. https:\/\/doi.org\/10.1038\/s41419-020-02787-1","journal-title":"Cell Death Dis"},{"key":"687_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10495-024-02019-3","volume":"30","author":"J Liang","year":"2025","unstructured":"Liang J, Ma M, Feng W et al (2025) Anti-PD-L1 blockade facilitates antitumor effects of radiofrequency ablation by improving tumor immune microenvironment in hepatocellular carcinoma. Apoptosis 30:55\u201368. https:\/\/doi.org\/10.1007\/s10495-024-02019-3","journal-title":"Apoptosis"},{"key":"687_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1158\/2326-6066.CIR-22-0379","volume":"11","author":"EY Faraoni","year":"2023","unstructured":"Faraoni EY, O\u2019Brien BJ, Strickland LN et al (2023) Radiofrequency ablation remodels the tumor microenvironment and promotes neutrophil-mediated abscopal immunomodulation in pancreatic cancer. Cancer Immunol Res 11:4\u201312. https:\/\/doi.org\/10.1158\/2326-6066.CIR-22-0379","journal-title":"Cancer Immunol Res"},{"key":"687_CR27","doi-asserted-by":"publisher","unstructured":"Xiao W, Huang H, Zheng P et al (2023) The CXCL10\/CXCR3 pathway contributes to the synergy of thermal ablation and PD-1 blockade therapy against tumors. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15051427","DOI":"10.3390\/cancers15051427"},{"key":"687_CR28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","volume":"9","author":"M Yi","year":"2024","unstructured":"Yi M, Li T, Niu M et al (2024) Targeting cytokine and chemokine signaling pathways for cancer therapy. Signal Transduct Target Ther 9:176. https:\/\/doi.org\/10.1038\/s41392-024-01868-3","journal-title":"Signal Transduct Target Ther"},{"key":"687_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/gutjnl-2015-310514","volume":"66","author":"X Li","year":"2017","unstructured":"Li X, Yao W, Yuan Y et al (2017) Targeting of tumour-infiltrating macrophages via CCL2\/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. Gut 66:157\u2013167. https:\/\/doi.org\/10.1136\/gutjnl-2015-310514","journal-title":"Gut"},{"key":"687_CR30","doi-asserted-by":"publisher","first-page":"e0128910","DOI":"10.1371\/journal.pone.0128910","volume":"10","author":"M Ahmed","year":"2015","unstructured":"Ahmed M, Kumar G, Navarro G et al (2015) Systemic siRNA nanoparticle-based drugs combined with radiofrequency ablation for cancer therapy. PLoS One 10:e0128910. https:\/\/doi.org\/10.1371\/journal.pone.0128910","journal-title":"PLoS One"},{"key":"687_CR31","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1148\/radiol.2015141695","volume":"276","author":"N Rozenblum","year":"2015","unstructured":"Rozenblum N, Zeira E, Scaiewicz V et al (2015) Oncogenesis: an \u201coff-target\u201d effect of radiofrequency ablation. Radiology 276:426\u2013432. https:\/\/doi.org\/10.1148\/radiol.2015141695","journal-title":"Radiology"},{"key":"687_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112585","volume":"138","author":"S Ju","year":"2024","unstructured":"Ju S, Duan X, Wang Y et al (2024) Blocking TGFbetaR synergistically enhances anti-tumor effects of anti-PD-1 antibody in a mouse model of incomplete thermal ablation. Int Immunopharmacol 138:112585. https:\/\/doi.org\/10.1016\/j.intimp.2024.112585","journal-title":"Int Immunopharmacol"},{"key":"687_CR33","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.4103\/jcrt.jcrt_1458_21","volume":"19","author":"N Zhang","year":"2023","unstructured":"Zhang N, Chen R, Cao X, Wang L (2023) Aberrantly expressed HIF-1alpha enhances HCC stem cell-like traits via Wnt\/beta-catenin signaling activation after insufficient radiofrequency ablation. J Cancer Res Ther 19:1517\u20131524. https:\/\/doi.org\/10.4103\/jcrt.jcrt_1458_21","journal-title":"J Cancer Res Ther"},{"key":"687_CR34","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.3389\/fimmu.2019.02526","volume":"10","author":"MW Loffler","year":"2019","unstructured":"Loffler MW, Nussbaum B, Jager G et al (2019) A non-interventional clinical trial assessing immune responses after radiofrequency ablation of liver metastases from colorectal cancer. Front Immunol 10:2526. https:\/\/doi.org\/10.3389\/fimmu.2019.02526","journal-title":"Front Immunol"},{"key":"687_CR35","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1158\/1078-0432.CCR-15-1352","volume":"22","author":"L Shi","year":"2016","unstructured":"Shi L, Chen L, Wu C et al (2016) PD-1 blockade boosts radiofrequency ablation-elicited adaptive immune responses against tumor. Clin Cancer Res 22:1173\u20131184. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-1352","journal-title":"Clin Cancer Res"},{"key":"687_CR36","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.3389\/fimmu.2019.02525","volume":"10","author":"M Zheng","year":"2019","unstructured":"Zheng M, Tian Z (2019) Liver-mediated adaptive immune tolerance. Front Immunol 10:2525. https:\/\/doi.org\/10.3389\/fimmu.2019.02525","journal-title":"Front Immunol"}],"container-title":["European Radiology Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-026-00687-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41747-026-00687-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-026-00687-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:55:05Z","timestamp":1775123705000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41747-026-00687-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["687"],"URL":"https:\/\/doi.org\/10.1186\/s41747-026-00687-1","relation":{},"ISSN":["2509-9280"],"issn-type":[{"value":"2509-9280","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiments of this study were performed from June 2018 to August 2023 after ethical approval by the Institutional Animal Care Committee of the Hadassah Hebrew University, Jerusalem, Israel (ethics committee #: MD-19-15781-5).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"An Association for Assessment and Accreditation of Laboratory Animal Care International certificate has been granted to this facility.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The following authors received funding or consulting fees not related to this research. LS received funding from Deutsche Forschungsgesellschaft. SNG received funding from the Israel Science Foundation and consulting fees from CAPS Medical, SNIPE Medical, and Cambridge International.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}